ARK001 is a novel investigational treatment with a proprietary formulation for the treatment of infantile hemangioma (IH)
ARK001 Technology
Once-daily, easy-to-apply topical gel
Becomes a self-forming film that adheres to the IH
Formulated to deliver treatment directly to the IH for 24 hours
The treatment is rapidly deactivated by blood vessels in the skin, minimizing systemic exposure